[Telomerase].

T, Ide; H, Tahara

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1996

Data sources: Europe PubMed Central

[Telomerase].

descriptionPublicationkeyboard_double_arrow_right Article 10 Sep 1996 Japanese Journal:Gan to kagaku ryoho. Cancer & chemotherapy, volume 23 (issn: 0385-0684,

Copyright policy )

Authors: T, Ide; H, Tahara;

pmid: 8712815

[Telomerase].

- Summary
- Subjects
- Metrics

Abstract

Telomerase is expected to be a powerful tool for cancer diagnosis and cancer chemotherapeutics because of its selective expression exclusively in various cancer tissues at a high frequency (90%) in human somatic tissues. Some precancerous tissues also express telomerase at a high frequency. Normal somatic tissues are mostly telomerase negative. Cancer cells die after a loss of telomerase activity.

Related Organizations

Hiroshima University
Japan

Keywords

Base Sequence, Liver, Neoplasms, Liver Neoplasms, Molecular Sequence Data, Humans, Apoptosis, Precancerous Conditions, Telomerase

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average